1. Stocks
    2. /
  2. Imugene Limited (ASX: IMU)
    3. /

Imugene Limited (ASX: IMU) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Imugene Limited Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • Imugene Limited (ASX: IMU)
    Latest News

    Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
    Share Fallers

    Why Imricor, Imugene, Newmont, and Pepper Money shares are falling today

    | James Mickleboro

    These shares are having a tough time on hump day. But why?

    Read more »

    A young woman wearing overalls and a yellow t-shirt kicks one leg in the air showing excitement over the latest ASX 200 shares to hit 52-week highs
    Share Gainers

    Why Clover, DroneShield, Imugene, and New Hope shares are racing higher today

    | James Mickleboro

    These shares are having a good time on hump day.

    Read more »

    A young man punches the air in delight as he reacts to great news on his mobile phone.
    Healthcare Shares

    Guess which ASX stock is surging 11% on big US FDA news

    | James Mickleboro

    Big news is lifting this stock higher on Wednesday. Let's find out what's happening.

    Read more »

    Two smiling work colleagues discuss an investment at their office.
    Share Gainers

    Why GQG, Imugene, Mirvac, and Temple & Webster shares are pushing higher

    | James Mickleboro

    These shares are ending the week on a positive note. But why?

    Read more »

    Three happy girls on jumping motion with inflatable mattresses at the beach.
    Share Gainers

    3 ASX All Ords shares leading the charge in 2025

    | Bernd Struben

    These ASX All Ords shares have soared 16% to 37% already in 2025.

    Read more »

    A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
    Share Gainers

    Why Cettire, Gold Road, Imugene, and Paladin Energy shares are racing higher

    | James Mickleboro

    These shares are ending the week with a bang. But why? Let's find out.

    Read more »

    Six smiling health workers pose for a selfie.
    Healthcare Shares

    Guess which ASX small cap stock is jumping on 'significant milestone'

    | James Mickleboro

    This stock is ending the week in style. Let's see what is giving its shares a boost today.

    Read more »

    a group of five women in business attire stand side by side with unhappy looks on their faces and holding their thumbs down.
    Share Fallers

    5 worst ASX All Ordinaries shares of 2024

    | Bronwyn Allen

    Shareholders of these ASX All Ordinaries stocks endured a teeth-gritting year.

    Read more »

    Woman on her laptop thinking to herself.
    Cheap Shares

    6 ASX shares down 50%+ in 2024. Are they cheap?

    | Sebastian Bowen

    A cheap share doesn't always mean a bargain.

    Read more »

    A man clenches his fists in excitement as gold coins fall from the sky.
    Share Gainers

    Why Imugene, Neuren, Sigma, and Smartgroup shares are charging higher

    | James Mickleboro

    These shares are ending the week on a high. But why? Let's find out.

    Read more »

    A young woman wearing overalls and a yellow t-shirt kicks one leg in the air showing excitement over the latest ASX 200 shares to hit 52-week highs
    Share Gainers

    Why Core Lithium, Imugene, Lifestyle Communities, and Mineral Resources shares are charging higher

    | James Mickleboro

    These shares are having a good session. What's going on?

    Read more »

    A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
    Share Market News

    Guess which ASX 300 stock is jumping 11% on big news

    | James Mickleboro

    Big news is giving this stock an even bigger lift on Tuesday. What's happening?

    Read more »

    Frequently Asked Questions

    Imugene does not pay dividends at this stage. 

    Imugene Ltd (ASX: IMU) listed on the ASX on 24 November 1993.

    IMU ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Imugene Limited

    Imugene Ltd (ASX: IMU) is a biotechnology company working in cancer immunotherapy.

    The company specialises in clinical-stage immuno-oncology therapies. Its product pipeline includes Oncolytic Virus and B-Cell Immunotherapies aimed at treating a variety of cancers in combination with standard-care drugs and immunotherapies.

    The company's lead product is HER-Vaxx, a proprietary cancer vaccine for the treatment of gastric and breast cancer, where the cancer is HER-2 positive. The vaccine has demonstrated it stimulates a polyclonal antibody response to HER2/neu. 

    Imugene's various immunotherapy products are involved in ongoing clinical trials involving cancer specialists and researchers worldwide.

    Profile

    since

    Note